Search Results - "Rezende, Suely M"

American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients by Schünemann, Holger J., Cushman, Mary, Burnett, Allison E., Kahn, Susan R., Beyer-Westendorf, Jan, Spencer, Frederick A., Rezende, Suely M., Zakai, Neil A., Bauer, Kenneth A., Dentali, Francesco, Lansing, Jill, Balduzzi, Sara, Darzi, Andrea, Morgano, Gian Paolo, Neumann, Ignacio, Nieuwlaat, Robby, Yepes-Nuñez, Juan J., Zhang, Yuan, Wiercioch, Wojtek

“…Background: Venous thromboembolism (VTE) is the third most common vascular disease. Medical inpatients, long-term care residents, persons with minor injuries,…”
Get full text

Variation of rs3754689 at lactase gene and inhibitors in admixed Brazilian patients with hemophilia A by Zuccherato, Luciana W, Elói-Santos, Silvana M, Jardim, Letícia L, Camelo, Ricardo M, Chaves, Daniel G, Souza, Renan P, Hollox, Edward J, Rezende, Suely M

Get full text

Building the National Program of Inherited Bleeding Disorders in Brazil by Rezende, Suely M., Jardim, Leticia L., Lúcia Magalhães, Vera, Teixeira Melo, Helder, Araujo, João Paulo B., Genovez, Guilherme

Get full text

Needs and challenges among physicians and researchers in thrombosis and hemostasis: Results from an international study by Murray, Suzanne, McLintock, Claire, Lazure, Patrice, Peniuta, Morgan, Schulman, Sam, Rezende, Suely M., Morrissey, James H., Reiser, Thomas, Pabinger, Ingrid

“…Specialty societies, such as the International Society on Thrombosis and Haemostasis (ISTH), are a key source of support for clinical and scientific…”
Get full text

High risk of venous thromboembolism after orthopedic surgery in patients with thrombophilia by Zambelli, Roberto, Nemeth, Banne, Touw, Carolina E., Rosendaal, Frits R., Rezende, Suely M., Cannegieter, Suzanne C.

“…Objective This study aimed at evaluating the effect of thrombophilia on the risk of venous thromboembolism (VTE) in patients undergoing any type of orthopedic…”
Get full text

Germline variants of the immune checkpoint proteins PD‐1, PD‐l1 and CTLA‐4 and immune tolerance induction outcome in patients with inherited haemophilia A by Zuccherato, Luciana W., Camelo, Ricardo M., Chaves, Daniel G., Rezende, Suely M.

Get full text

International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology by Rezende, Suely M., Neumann, Ignacio, Angchaisuksiri, Pantep, Awodu, Omolade, Boban, Ana, Cuker, Adam, Curtin, Julie A., Fijnvandraat, Karin, Gouw, Samantha C., Gualtierotti, Roberta, Makris, Michael, Nahuelhual, Paula, O’Connell, Niamh, Saxena, Renu, Shima, Midori, Wu, Runhui, Rosendaal, Frits R.

“…Hemophilia is a rare congenital bleeding disorder that results from complete or partial deficiency of blood coagulation factor (F)VIII (hemophilia A) or FIX…”
Get full text

Reported prevalence of von Willebrand disease worldwide in relation to income classification by Stonebraker, Jeffrey S., Iorio, Alfonso, Lavin, Michelle, Rezende, Suely M., Srivastava, Alok, Pierce, Glenn F., Coffin, Donna, Tootoonchian, Ellia, Makris, Michael

“…Introduction The diagnosis of von Willebrand disease (VWD) is complex and challenging, especially when diagnostic resources are limited. This results in a lack…”
Get full text

Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation by Barnes, Geoffrey D., Ageno, Walter, Castellucci, Lana A., Chiasakul, Thita, Eslick, Renee, Ferreiro, José L., Gailani, David, Gorog, Diana A., Lip, Gregory Y.H., Raffini, Leslie, Rezende, Suely M., Weitz, Jeffrey I., Cuker, Adam

“…Oral anticoagulation therapy has evolved beyond vitamin K antagonists to include oral direct thrombin inhibitors and factor Xa inhibitors. Collectively known…”
Get full text

Recurrence after stopping anticoagulants in women with combined oral contraceptive‐associated venous thromboembolism: a systematic review and meta‐analysis by Abdulrehman, Jameel, Elbaz, Carolyne, Aziz, David, Parpia, Sameer, Fazelzad, Rouhi, Eischer, Lisbeth, Rodger, Marc A., Cannegieter, Suzanne C., ten Cate‐Hoek, Arina, Nagler, Michael, Schulman, Sam, Rezende, Suely M., Olié, Valérie, Palareti, Gualtiero, Marcucci, Maura, Douketis, James, Poli, Daniela, Zabczyk, Michal, Aguiar de Sousa, Diana, André e Silva Miranda, Bruno, Cushman, Mary, Tosetto, Alberto, Le Gal, Gregoire, Kearon, Clive, Skeith, Leslie

“…© 2022 British Society for Haematology and John Wiley & Sons Ltd. The risk of recurrence after discontinuation of anticoagulation for a combined oral…”
Get full text

Risk factors for antibody formation in children with hemophilia: methodological aspects and clinical characteristics of the HEMFIL cohort study by Jardim, Letícia L., Santana, Marcio P., Chaves, Daniel G., van der Bom, Johanna, Rezende, Suely M.

“…Up to 35% of patients with hemophilia A and 5% with hemophilia B develop neutralizing antibodies which can inhibit the therapeutic activity of factor…”
Get full text

Prevalence of sporadic haemophilia A by Santana, Márcio A. P., Chaves, Daniel G., Camelo, Ricardo M., Zuccherato, Luciana W., Jardim, Letícia L., Rezende, Suely M.

Get full text

Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines by Wiercioch, Wojtek, Nieuwlaat, Robby, Dahm, Philipp, Iorio, Alfonso, Mustafa, Reem A., Neumann, Ignacio, Rochwerg, Bram, Manja, Veena, Alonso-Coello, Pablo, Ortel, Thomas L., Santesso, Nancy, Vesely, Sara K., Akl, Elie A., Schünemann, Holger J.

“…•Health outcome descriptors (HODs) explicitly define health outcomes based on experiences of affected individuals or patients.•Use of HODs facilitated the…”
Get full text

Thromboprophylaxis in hospitalized and nonhospitalized medical patients: what’s new? by Rezende, Suely M., Bauer, Kenneth A., Zakai, Neil A.

Get full text

ASH Clinical Practice Guidelines: strategies to stay up-to-date by Cheung, Matthew C., Kunkle, Rob, Plovnick, Rob, Lottenberg, Richard, Rezende, Suely M., Silverstein, Roy, Pai, Menaka, Seftel, Matthew, Cuker, Adam

Get full text

Risk factors associated with recurrent venous thromboembolism after a first cerebral venous thrombosis event: A cohort study by Pires, Giselli S., Ribeiro, Daniel D., Oliveira, João A.Q., Freitas, Luís C., Vaez, Rodrigo, Annichino-Bizzacchi, Joyce M., Morelli, Vânia M., Rezende, Suely M.

“…Cerebral venous thrombosis (CVT), although rare, is potentially fatal. Few studies have investigated risk factors associated with recurrent venous…”
Get full text

TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain by Reglińska-Matveyev, Natalia, Andersson, Helena M., Rezende, Suely M., Dahlbäck, Björn, Crawley, James T.B., Lane, David A., Ahnström, Josefin

“…Protein S is a cofactor for tissue factor pathway inhibitor (TFPI), accelerating the inhibition of activated factor X (FXa). TFPI Kunitz domain 3 residue…”
Get full text

Inhibitor incidence in haemophilia A under exclusive use of a third‐generation recombinant factor VIII concentrate: results of the HEMFIL Cohort Study by Jardim, Letícia L., Bom, Johanna, Brommonschenkel, Christina C., Gouw, Samantha C., Rezende, Suely M.

Get full text

Identifying experts for clinical practice guidelines: perspectives from the ASH Guideline Oversight Subcommittee by Byrne, Michael, Mattison, Ryan, Bercovitz, Rachel, Lottenberg, Richard, Rezende, Suely M., Silverstein, Roy, Terrell, Deirdra, Kunkle, Rob, Smith, Deion, Bollard, Catherine, Haberichter, Sandra, Holter-Chakrabarty, Jennifer, Pai, Menaka, Cheung, Matthew, Cuker, Adam, Seftel, Matthew, Djulbegovic, Benjamin

Get full text

Haemostatic genetic risk factors in arterial thrombosis by Simmonds, R E, Hermida, J, Rezende, S M, Lane, D A

“…Haemostasis plays an integral role in arterial thrombotic disease. However, establishing which of the factors are risk factors has proven surprisingly…”
Get more information